Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapyThomas Georgi, Vladan Vučinić, Klaus H. Metzeler et al.|Journal of Cancer Research and Clinical Oncology|2023Cited by 25
Cellular dynamics and their impact on outcome in patients with mantle cell lymphoma during treatment with chimeric antigen receptor (CAR) T cellsR. Weiß, Vladan Vučinić, C. P. Fernandez et al.|Hematological Oncology|2023Cited by 0
P1415: CELLULAR DYNAMICS IN RESPONDERS AND NON-RESPONDERS AFTER THE TREATMENT OF PATIENTS WITH AGGRESSIVE B-ZELL LYMPHOMAS WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLSThomas Georgi, Vladan Vučinić, Carmen Fernandez-Perez et al.|HemaSphere|2023Cited by 0
P-105 PET/CT Has Prognostic Significance for CAR T Cell Therapy in Relapsed/Refractory Multiple MyelomaPatrick Born, Maximilan Merz, David Fandrei et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 0